methylprednisolone (Q417222)

subject named as

Methylprednisolone

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

2 September 2022

chemical formula

C₂₂H₃₀O₅

1 reference

methylprednisolone (English)

17 November 2016

canonical SMILES

CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O

1 reference

methylprednisolone (English)

17 November 2016

isomeric SMILES

C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O

1 reference

methylprednisolone (English)

17 November 2016

defined daily dose

7.5 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=H02AB04

20 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=H02AB04

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

methylprednisolone (English)

1 reference

6alpha-methylprednisolone (English)

medical condition treated

3 October 2016

graft-versus-host disease

3 references

13 December 2016

2 October 2018

https://www.ncbi.nlm.nih.gov/pubmed/6367162

1 reference

13 December 2016

1 reference

hematopoietic system disease

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

osteoarthritis susceptibility 1

2 October 2018

1 reference

interstitial lung disease

2 October 2018

1 reference

2 October 2018

sinusitis

1 reference

acute graft versus host disease

2 October 2018

1 reference

2 October 2018

optic neuritis

1 reference

2 October 2018

arthritis

1 reference

relapsing-remitting multiple sclerosis

2 October 2018

1 reference

2 October 2018

nephrotic syndrome

1 reference

2 October 2018

multiple sclerosis

1 reference

congenital adrenal hyperplasia

2 October 2018

start time

23 October 1957

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

rheumatoid arthritis

start time

23 October 1957

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

contact dermatitis

start time

23 October 1957

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/X4W7ZR7023

http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011153s051lbl.pdf

significant drug interaction

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

retroperitoneal hemorrhage

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

tendon rupture

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Nuclear receptor subfamily 3 group C member 1

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7088

Australian pregnancy category A

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

https://www.pfizer.com/products/product-list

mass

374.209 dalton

1 reference

methylprednisolone (English)

selective glucocorticoid receptor agonist

17 November 2016

subject has role

5-lipoxygenase inhibitor

1 reference

5 March 2018

1 reference

5 March 2018

neuroprotective agent

1 reference

MeSH descriptor ID

D008775

15 March 2018

anti-inflammatory agent

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1

15 March 2018

0 references

0 references

Methylprednisolone

0 references

Identifiers

InChI

1 reference

methylprednisolone (English)

17 November 2016

2 references

methylprednisolone (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

83-43-2

2 references

methylprednisolone (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=83-43-2

9 April 2021

1 reference

Methylprednisolone (English)

17 November 2016

2 references

methylprednisolone (English)

17 November 2016

Reaxys registry number

2340300

1 reference

6alpha-methylprednisolone (English)

3 October 2016

ChEBI ID

6888

mapping relation type

2 references

METHYLPREDNISOLONE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1

1 reference

METHYLPREDNISOLONE (English)

17 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU107601

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU107602

0 references

MSBNK-Athens_Univ-AU107603

0 references

MSBNK-Athens_Univ-AU107604

0 references

MSBNK-Athens_Univ-AU107605

0 references

MSBNK-Athens_Univ-AU107607

0 references

MSBNK-Athens_Univ-AU107608

0 references

MSBNK-Athens_Univ-AU107609

0 references

MSBNK-Athens_Univ-AU107610

0 references

MSBNK-Athens_Univ-AU107611

0 references

MSBNK-Athens_Univ-AU107630

0 references

MSBNK-Athens_Univ-AU107631

0 references

MSBNK-Athens_Univ-AU107632

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

splash10-0k9i-0696000000-003c4527b983cf71aefd

0 references

splash10-01p9-0980000000-e5097669b38e84057a0f

0 references

splash10-01p9-0960000000-ef914702163187cc80af

0 references

splash10-06y9-0940000000-54b01b6c04c68be3f1b3

0 references

splash10-0a4i-0009000000-3fe2869617af3697e2ed

0 references

splash10-0a4i-0009000000-8ad4f169606968256614

0 references

splash10-0f79-0895000000-29d1cbf49bb2b32c5a98

0 references

splash10-01p9-0940000000-baa402ac94c228229ea2

0 references

splash10-01p9-0910000000-5cf9fb219d798a9316f4

0 references

splash10-0a4r-0910000000-a2d2af7f573229dc3147

0 references

splash10-0006-2900000000-a01d5bfe926dc48e6e4c

0 references

splash10-0a4i-0019000000-11519ee9583104c00505

0 references

splash10-0gw0-0974000000-af5d4ebce055ce6efb23

0 references

splash10-01p9-0960000000-22e2342fcec2bf1cd833

0 references

splash10-01p9-0920000000-63759535c53af1efb13f

0 references

splash10-0c09-1900000000-a48c07db31cf27cf0381

0 references

splash10-05tp-2900000000-b802f5e17b69cd6c707f

0 references

splash10-0a4i-0009000000-0e0cc8bfc7721357c5cf

0 references

splash10-0bti-0896000000-86854a3fa2cb3c3bde0b

0 references

splash10-0a4r-0796000000-b0070da713077c3f7975

0 references

splash10-01p9-3950000000-b938f656c358e1e42bb5

0 references

splash10-0fe0-0149000000-e2764c4911c33cde9fad

0 references

HSDB ID

3127

1 reference

Hazardous Substances Data Bank

28 October 2019

METHYLPREDNISOLONE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

methylprednisolone (English)

ECHA Substance Infocard ID

17 November 2016

100.001.343

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.001.343

27 December 2018

Methylprednisolone (English)

quotation

CAS no.: 83-43-2 (English)

1 reference

Methylprednisolone (English)

17 November 2015

1 reference

Methylprednisolone (English)

17 November 2015

1 reference

Guide to Pharmacology Ligand ID

Methylprednisolone (English)

17 November 2015

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

7088

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7088

D04.210.500.745.432.769.795.539

methylprednisolone (English)

17 November 2016

Methylprednisolone

0 references

MeSH concept ID

M0013662

0 references

MeSH tree code

0 references

1 reference

methylprednisolone (English)

17 November 2016

DrugBank ID

DB00959

1 reference

Human Metabolome Database ID

HMDB0015094

2 references

based on heuristic

inferred from InChIKey

2 references

methylprednisolone (English)

17 November 2016

MedlinePlus drug identifier

a682795

oral administration

0 references

a601157

PatientsLikeMe treatment ID

intramuscular injection

intravenous injection

0 references

0 references

1 reference

methylprednisolone (English)

17 November 2016

0 references

1 reference

1 reference

http://www.lipidmaps.org/rest/compound/lm_id/LM/all/download

6alpha-methylprednisolone (English)

3 October 2016

1 reference

electronic Essential Medicines List medicine ID

30 June 2018

DeCS ID

22562

0 references

0 references

1 reference

28 October 2013

Microsoft Academic ID (discontinued)

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1 reference

methylprednisolone (English)